Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tatnic who wrote (6302)	4/8/1999 1:02:00 AM
From: Bruce Rosen	Read Replies (2) of 7041

It seems when this stock looks weakest, it begins to rise. Conversely, when it looks strongest, it has a tendency to fall. I guess this is a by-product of waiting for a short term future-defining FDA decision. At least this drop has been on fairly low volume. The DLJ analyst following Schering issued a report yesterday. He estimated that if approved, Vasomax would generate $30 million in sales in the latter part of 1999 and $100 million or more next year. If it is true that the class action against Zonagen has been dismissed by the judge, it further shows the irresponsible nature of Asensio's claims about Zonagen. Whatever you might believe about the prospects for Vasomax, his assertions were nothing but deliberately distorted self serving diatribes, not well researched analysis. His so called "facts" couldn't even get a case to trial, much less a judgement or settlement. Good luck, Bruce

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next